Ammonia and Its Role in the Pathogenesis of Hepatic Encephalopathy

Clinics in Liver Disease

Volumn 19, Issue 3, 2015, Pages 529-537

  Parekh, Parth J ^a   Balart, Luis A ^a  

^a TULANE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Ammonia; Astrocyte swelling; GABA; Glutamate; Glutamine; Hepatic encephalopathy; Urea cycle

Indexed keywords

4 AMINOBUTYRIC ACID; AMMONIA; GLUTAMINE;

AMMONIA BLOOD LEVEL; ASTROCYTE; BLOOD BRAIN BARRIER; CELL SWELLING; CHRONIC LIVER DISEASE; COGNITIVE DEFECT; DISEASE CLASSIFICATION; HEPATIC ENCEPHALOPATHY; HUMAN; INTESTINE FLORA; LIVER CIRRHOSIS; MORBIDITY; MORTALITY; OXIDATIVE STRESS; PATHOGENESIS; REVIEW; UREA CYCLE; ANIMAL; BLOOD; CHRONIC DISEASE; CLASSIFICATION; COMPLICATION; LIVER DISEASE; METABOLISM; PATHOLOGY;

AMMONIA; ANIMALS; ASTROCYTES; BLOOD-BRAIN BARRIER; CHRONIC DISEASE; GAMMA-AMINOBUTYRIC ACID; GLUTAMINE; HEPATIC ENCEPHALOPATHY; HUMANS; LIVER DISEASES;

EID: 84946496090     PISSN: 10893261     EISSN: 15578224     Source Type: Journal    
DOI: 10.1016/j.cld.2015.05.002     Document Type: Review

References (40)

1. Stepanova M., Mishra A., Venkatesan C., et al. In-hospital mortality and economic burden associated with hepatic encephalopathy in the United States from 2005 to 2009. Clin Gastroenterol Hepatol 2012, 10(9):1034-1041.e1.
2. Wu G., Knabe D.A., Yan W., et al. Glutamine and glucose metabolism in enterocytes of the neonatal pig. Am J Physiol 1995, 268(2 Pt 2):R334-R342.
3. Richardson A.J., Mckain N., Wallace R.J. Ammonia production by human faecal bacteria, and the enumeration, isolation and characterization of bacteria capable of growth on peptides and amino acids. BMC Microbiol 2013, 13:6.
4. Schulz C., Schütte K., Malfertheiner P., et al. Does H. pylori eradication therapy benefit patients with hepatic encephalopathy?: systematic review. J Clin Gastroenterol 2014, 48(6):491-499.
5. Kountouras J., Zavos C., Deretzi G. Helicobacter pylori might contribute to persistent cognitive impairment after resolution of overt hepatic encephalopathy. Clin Gastroenterol Hepatol 2011, 9(7):624.
6. Chen S.J., Wang L.J., Zhu Q., et al. Effect of H pylori infection and its eradication on hyperammonemia and hepatic encephalopathy in cirrhotic patients. World J Gastroenterol 2008, 14(12):1914-1918.
7. Zullo A., Hassan C., Morini S. Hepatic encephalopathy and Helicobacter pylori: a critical reappraisal. J Clin Gastroenterol 2003, 37(2):164-168.
8. Poh Z., Chang P.E. A current review of the diagnostic and treatment strategies of hepatic encephalopathy. Int J Hepatol 2012, 2012:480309.
9. Brusilow S.W. Hyperammonemic encephalopathy. Medicine (Baltimore) 2002, 81(3):240-249.
10. Häussinger D., Kircheis G., Fischer R., et al. Hepatic encephalopathy in chronic liver disease: a clinical manifestation of astrocyte swelling and low-grade cerebral edema?. J Hepatol 2000, 32(6):1035-1038.
11. Häussinger D., Schliess F. Pathogenetic mechanisms of hepatic encephalopathy. Gut 2008, 57(8):1156-1165.
12. Miese F., Kircheis G., Wittsack H.J., et al. 1H-MR spectroscopy, magnetization transfer, and diffusion-weighted imaging in alcoholic and nonalcoholic patients with cirrhosis with hepatic encephalopathy. AJNR Am J Neuroradiol 2006, 27(5):1019-1026.
13. Zhang X.D., Zhang L.J., Wu S.Y., et al. Multimodality magnetic resonance imaging in hepatic encephalopathy: an update. World J Gastroenterol 2014, 20(32):11262-11272.
14. Ahboucha S., Talani G., Fanutza T., et al. Reduced brain levels of DHEAS in hepatic coma patients: significance for increased GABAergic tone in hepatic encephalopathy. Neurochem Int 2012, 61(1):48-53.
15. Sergeeva O.A. GABAergic transmission in hepatic encephalopathy. Arch Biochem Biophys 2013, 536(2):122-130.
16. Reinehr R., Görg B., Becker S., et al. Hypoosmotic swelling and ammonia increase oxidative stress by NADPH oxidase in cultured astrocytes and vital brain slices. Glia 2007, 55(7):758-771.
17. Görg B., Qvartskhava N., Bidmon H.J., et al. Oxidative stress markers in the brain of patients with cirrhosis and hepatic encephalopathy. Hepatology 2010, 52(1):256-265.
18. Görg B., Karababa A., Shafigullina A., et al. Ammonia-induced senescence in cultured rat astrocytes and in human cerebral cortex in hepatic encephalopathy. Glia 2015, 63(1):37-50.
19. Riggio O., Ridola L., Pasquale C., et al. Evidence of persistent cognitive impairment after resolution of overt hepatic encephalopathy. Clin Gastroenterol Hepatol 2011, 9(2):181-183.
20. Bajaj J.S., Schubert C.M., Heuman D.M., et al. Persistence of cognitive impairment after resolution of overt hepatic encephalopathy. Gastroenterology 2010, 138(7):2332-2340.
21. Umapathy S., Dhiman R.K., Grover S., et al. Persistence of cognitive impairment after resolution of overt hepatic encephalopathy. Am J Gastroenterol 2014, 109(7):1011-1019.
22. Lockwood A.H., Yap E.W., Wong W.H. Cerebral ammonia metabolism in patients with severe liver disease and minimal hepatic encephalopathy. J Cereb Blood Flow Metab 1991, 11(2):337-341.
23. Guevara M., Baccaro M.E., Torre A., et al. Hyponatremia is a risk factor of hepatic encephalopathy in patients with cirrhosis: a prospective study with time-dependent analysis. Am J Gastroenterol 2009, 104(6):1382-1389.
24. Dasarathy S., Mullen K.D. Benzodiazepines in hepatic encephalopathy: sleeping with the enemy. Gut 1998, 42(6):764-765.
25. Seyan A.S., Hughes R.D., Shawcross D.L. Changing face of hepatic encephalopathy: role of inflammation and oxidative stress. World J Gastroenterol 2010, 16(27):3347-3357.
26. Albrecht J., Norenberg M.D. Glutamine: a Trojan horse in ammonia neurotoxicity. Hepatology 2006, 44(4):788-794.
27. Poveda M.J., Bernabeu A., Concepción L., et al. Brain edema dynamics in patients with overt hepatic encephalopathy: A magnetic resonance imaging study. Neuroimage 2010, 52(2):481-487.
28. Sobczyk K., Jördens M.S., Karababa A., et al. Ephrin/Ephrin receptor expression in ammonia-treated rat astrocytes and in human cerebral cortex in hepatic encephalopathy. Neurochem Res 2015, 40(2):274-283.
29. Panickar K.S., Jayakumar A.R., Rama Rao K.V., et al. Downregulation of the 18-kDa translocator protein: effects on the ammonia-induced mitochondrial permeability transition and cell swelling in cultured astrocytes. Glia 2007, 55(16):1720-1727.
30. Ahboucha S., Butterworth R.F. Pathophysiology of hepatic encephalopathy: a new look at GABA from the molecular standpoint. Metab Brain Dis 2004, 19(3-4):331-343.
31. Jones E.A. Ammonia, the GABA neurotransmitter system, and hepatic encephalopathy. Metab Brain Dis 2002, 17(4):275-281.
32. Ahboucha S., Gamrani H., Baker G. GABAergic neurosteroids: the "endogenous benzodiazepines" of acute liver failure. Neurochem Int 2012, 60(7):707-714.
33. Butterworth R.F. The astrocytic ("peripheral-type") benzodiazepine receptor: role in the pathogenesis of portal-systemic encephalopathy. Neurochem Int 2000, 36(4-5):411-416.
34. Ahboucha S. Neurosteroids and hepatic encephalopathy: an update on possible pathophysiologic mechanisms. Curr Mol Pharmacol 2011, 4(1):1-13.
35. Leke R., Bak L.K., Schousboe A., et al. Demonstration of neuron-glia transfer of precursors for GABA biosynthesis in a co-culture system of dissociated mouse cerebral cortex. Neurochem Res 2008, 33(12):2629-2635.
36. Leke R., Bak L.K., Iversen P., et al. Synthesis of neurotransmitter GABA via the neuronal tricarboxylic acid cycle is elevated in rats with liver cirrhosis consistent with a high GABAergic tone in chronic hepatic encephalopathy. J Neurochem 2011, 117(5):824-832.
37. Goulenok C., Bernard B., Cadranel J.F., et al. Flumazenil vs. placebo in hepatic encephalopathy in patients with cirrhosis: a meta-analysis. Aliment Pharmacol Ther 2002, 16(3):361-372.
38. Keitel V., Görg B., Bidmon H.J., et al. The bile acid receptor TGR5 (Gpbar-1) acts as a neurosteroid receptor in brain. Glia 2010, 58(15):1794-1805.
39. Ferenci P., Lockwood A., Mullen K., et al. Hepatic encephalopathy-definition, nomenclature, diagnosis, and quantification: final report of the working party at the 11th World Congresses of Gastroenterology, Vienna, 1998. Hepatology 2002, 35(3):716-721.
40. Gundling F., Zelihic E., Seidl H., et al. How to diagnose hepatic encephalopathy in the emergency department. Ann Hepatol 2013, 12(1):108-114.